Doxorubicin immunoconjugates containing bivalent, lysosomally-cleavable dipeptide linkages

被引：31

作者：

Dubowchik, GM

Radia, S

Mastalerz, H

Walker, MA

Firestone, RA

King, HD

Hofstead, SJ

Willner, D

Lasch, SJ

Trail, PA

机构：

[1] Bristol Myers Squibb Pharmaceut Res Inst, Wallingford, CT 06492 USA

[2] Bristol Myers Squibb Pharmaceut Res Inst, Princeton, NJ 08543 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2002年 / 12卷 / 11期

关键词：

D O I：

10.1016/S0960-894X(02)00194-4

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Bivalent doxorubicin (DOX)-dipeptides (16a-c) were prepared and conjugated to the monoclonal antibody BR96. The dipeptides are cleaved by lysosomal proteases following internalization of the resulting immunoconjugates. Conjugate 18b demonstrated antigen-specific in vitro tumor cell killing activity (IC50 = 0.2 muM) that was equipotent to DOX with a near doubling of drug molecules/MAb. Size exclusion chromatography showed 18b to be a noncovalent dimer that was formed immediately upon conjugation. (C) 2002 Elsevier Science Ltd. All rights reserved.

引用

页码：1529 / 1532

页数：4

共 10 条

[1] A NOVEL CONNECTOR LINKAGE APPLICABLE IN PRODRUG DESIGN
CARL, PL
CHAKRAVARTY, PK
KATZENELLENBOGEN, JA
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 1981, 24 (05) : 479 - 480
[2] Receptor-mediated and enzyme-dependent targeting of cytotoxic anticancer drugs
Dubowchik, GM
Walker, MA
[J]. PHARMACOLOGY & THERAPEUTICS, 1999, 83 (02) : 67 - 123
[3] Monomethoxytrityl (MMT) as a versatile amino protecting group for complex prodrugs of anticancer compounds sensitive to strong acids, bases and nucleophiles
Dubowchik, GM
Radia, S
[J]. TETRAHEDRON LETTERS, 1997, 38 (30) : 5257 - 5260
[4] Cathepsin B-sensitive dipeptide prodrugs. 1. A model study of structural requirements for efficient release of doxorubicin
Dubowchik, GM
Firestone, RA
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (23) : 3341 - 3346
[5] DUBOWCHIK GM, UNPUB
[6] FINBLOOM DS, 1980, J IMMUNOL, V125, P1060
[7] Monoclonal antibody conjugates of doxorubicin prepared with branched linkers:: A novel method for increasing the potency of doxorubicin immunoconjugates
King, HD
Yurgaitis, D
Willner, D
Firestone, RA
Yang, MB
Lasch, SJ
Hellström, KE
Trail, PA
[J]. BIOCONJUGATE CHEMISTRY, 1999, 10 (02) : 279 - 288
[8] LAWSON W B, 1968, Z. Physiol. Chem., V349, P251
[9] CURE OF XENOGRAFTED HUMAN CARCINOMAS BY BR96-DOXORUBICIN IMMUNOCONJUGATES
TRAIL, PA
WILLNER, D
LASCH, SJ
HENDERSON, AJ
HOFSTEAD, S
CASAZZA, AM
FIRESTONE, RA
HELLSTROM, I
HELLSTROM, KE
[J]. SCIENCE, 1993, 261 (5118) : 212 - 215
[10] (6-MALEIMIDOCAPROYL)HYDRAZONE OF DOXORUBICIN - A NEW DERIVATIVE FOR THE PREPARATION OF IMMUNOCONJUGATES OF DOXORUBICIN
WILLNER, D
TRAIL, PA
HOFSTEAD, SJ
KING, HD
LASCH, SJ
BRASLAWSKY, GR
GREENFIELD, RS
KANEKO, T
FIRESTONE, RA
[J]. BIOCONJUGATE CHEMISTRY, 1993, 4 (06) : 521 - 527

← 1 →